MARKET

SILO

SILO

Silo Pharma Inc
NASDAQ
0.2930
-0.0096
-3.17%
Closed 19:57 02/18 EST
OPEN
0.3300
PREV CLOSE
0.3026
HIGH
0.3510
LOW
0.2210
VOLUME
3.28M
TURNOVER
0
52 WEEK HIGH
1.520
52 WEEK LOW
0.2210
MARKET CAP
3.90M
P/E (TTM)
-0.3163
1D
5D
1M
3M
1Y
5Y
1D
Silo Pharma receives Notice of Allowance in Japan for SPC-15
TipRanks · 20h ago
Silo Pharma Gets Notice Of Allowance From Japan Patent Office For Patent Application Covering SPC-15
Benzinga · 20h ago
SILO PHARMA RECEIVES NOTICE OF ALLOWANCE IN JAPAN FOR SPC-15, EXPANDING GLOBAL INTELLECTUAL PROPERTY PORTFOLIO
Reuters · 20h ago
Silo Pharma Receives Japan Notice of Allowance for SPC-15 PTSD Intranasal Therapy Patent Application
Reuters · 20h ago
SILO PHARMA INC - RECEIVES NOTICE OF ALLOWANCE FROM JAPAN PATENT OFFICE
Reuters · 20h ago
Weekly Report: what happened at SILO last week (0209-0213)?
Weekly Report · 3d ago
Weekly Report: what happened at SILO last week (0202-0206)?
Weekly Report · 02/09 09:43
Weekly Report: what happened at SILO last week (0126-0130)?
Weekly Report · 02/02 09:42
More
About SILO
Silo Pharma, Inc. is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company. The Company’s therapeutic focus is on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The Company’s portfolio includes programs, such as for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Its lead product candidate, SPC-15, is designed as a novel serotonin 4 (5-HT4) receptor agonist that utilizes biomarkers for treatment of stress-induced psychiatric disorders such as PTSD and anxiety disorders. SPC-14 targets glutamate receptor NDMAR and serotonin 5-HT4 to address cognitive and neuropsychiatric symptoms in Alzheimer’s disease. SPU-16 is a candidate targeting central nervous system (CNS) disorders, with an initial indication for multiple sclerosis.

Webull offers Silo Pharma Inc stock information, including NASDAQ: SILO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SILO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SILO stock methods without spending real money on the virtual paper trading platform.